Abstract
Summary
According to our LPI (LP Information) latest study, the global Breast Cancer Liquid Biopsy market size was valued at US$ 1562.8 million in 2023. With growing demand in downstream market, the Breast Cancer Liquid Biopsy is forecast to a readjusted size of US$ 2226.5 million by 2030 with a CAGR of 5.2% during review period.
The research report highlights the growth potential of the global Breast Cancer Liquid Biopsy market. Breast Cancer Liquid Biopsy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Breast Cancer Liquid Biopsy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Breast Cancer Liquid Biopsy market.
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
Key Features:
The report on Breast Cancer Liquid Biopsy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Breast Cancer Liquid Biopsy market. It may include historical data, market segmentation by Type (e.g., Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Breast Cancer Liquid Biopsy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Breast Cancer Liquid Biopsy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Breast Cancer Liquid Biopsy industry. This include advancements in Breast Cancer Liquid Biopsy technology, Breast Cancer Liquid Biopsy new entrants, Breast Cancer Liquid Biopsy new investment, and other innovations that are shaping the future of Breast Cancer Liquid Biopsy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Breast Cancer Liquid Biopsy market. It includes factors influencing customer ' purchasing decisions, preferences for Breast Cancer Liquid Biopsy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Breast Cancer Liquid Biopsy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Breast Cancer Liquid Biopsy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Breast Cancer Liquid Biopsy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Breast Cancer Liquid Biopsy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Breast Cancer Liquid Biopsy market.
Market Segmentation:
Breast Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Circulating Tumor Cells (CTCs)
Cell-Free DNA (CfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
Segmentation by application
Hospitals
Diagnostic Centers
Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
QIAGEN
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini Silicon Biosystems
Genomic Health
Thermo Fisher Scientific
Illumina
Biocept
Trovagene
Guardant Health
RainDance Technologies
MDx Health
The research report highlights the growth potential of the global Breast Cancer Liquid Biopsy market. Breast Cancer Liquid Biopsy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Breast Cancer Liquid Biopsy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Breast Cancer Liquid Biopsy market.
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
Key Features:
The report on Breast Cancer Liquid Biopsy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Breast Cancer Liquid Biopsy market. It may include historical data, market segmentation by Type (e.g., Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Breast Cancer Liquid Biopsy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Breast Cancer Liquid Biopsy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Breast Cancer Liquid Biopsy industry. This include advancements in Breast Cancer Liquid Biopsy technology, Breast Cancer Liquid Biopsy new entrants, Breast Cancer Liquid Biopsy new investment, and other innovations that are shaping the future of Breast Cancer Liquid Biopsy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Breast Cancer Liquid Biopsy market. It includes factors influencing customer ' purchasing decisions, preferences for Breast Cancer Liquid Biopsy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Breast Cancer Liquid Biopsy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Breast Cancer Liquid Biopsy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Breast Cancer Liquid Biopsy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Breast Cancer Liquid Biopsy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Breast Cancer Liquid Biopsy market.
Market Segmentation:
Breast Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Circulating Tumor Cells (CTCs)
Cell-Free DNA (CfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
Segmentation by application
Hospitals
Diagnostic Centers
Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
QIAGEN
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini Silicon Biosystems
Genomic Health
Thermo Fisher Scientific
Illumina
Biocept
Trovagene
Guardant Health
RainDance Technologies
MDx Health
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Breast Cancer Liquid Biopsy Market Size 2019-2030
2.1.2 Breast Cancer Liquid Biopsy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Breast Cancer Liquid Biopsy Segment by Type
2.2.1 Circulating Tumor Cells (CTCs)
2.2.2 Cell-Free DNA (CfDNA)
2.2.3 Extracellular Vesicles (EVs)
2.2.4 Other Circulating Biomarkers
2.3 Breast Cancer Liquid Biopsy Market Size by Type
2.3.1 Breast Cancer Liquid Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
2.4 Breast Cancer Liquid Biopsy Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Centers
2.4.3 Laboratories
2.5 Breast Cancer Liquid Biopsy Market Size by Application
2.5.1 Breast Cancer Liquid Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
3 Breast Cancer Liquid Biopsy Market Size by Player
3.1 Breast Cancer Liquid Biopsy Market Size Market Share by Players
3.1.1 Global Breast Cancer Liquid Biopsy Revenue by Players (2019-2024)
3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Breast Cancer Liquid Biopsy by Regions
4.1 Breast Cancer Liquid Biopsy Market Size by Regions (2019-2024)
4.2 Americas Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.3 APAC Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.4 Europe Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.5 Middle East & Africa Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
5 Americas
5.1 Americas Breast Cancer Liquid Biopsy Market Size by Country (2019-2024)
5.2 Americas Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
5.3 Americas Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breast Cancer Liquid Biopsy Market Size by Region (2019-2024)
6.2 APAC Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
6.3 APAC Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Breast Cancer Liquid Biopsy by Country (2019-2024)
7.2 Europe Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
7.3 Europe Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Breast Cancer Liquid Biopsy by Region (2019-2024)
8.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
8.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Breast Cancer Liquid Biopsy Market Forecast
10.1 Global Breast Cancer Liquid Biopsy Forecast by Regions (2025-2030)
10.1.1 Global Breast Cancer Liquid Biopsy Forecast by Regions (2025-2030)
10.1.2 Americas Breast Cancer Liquid Biopsy Forecast
10.1.3 APAC Breast Cancer Liquid Biopsy Forecast
10.1.4 Europe Breast Cancer Liquid Biopsy Forecast
10.1.5 Middle East & Africa Breast Cancer Liquid Biopsy Forecast
10.2 Americas Breast Cancer Liquid Biopsy Forecast by Country (2025-2030)
10.2.1 United States Breast Cancer Liquid Biopsy Market Forecast
10.2.2 Canada Breast Cancer Liquid Biopsy Market Forecast
10.2.3 Mexico Breast Cancer Liquid Biopsy Market Forecast
10.2.4 Brazil Breast Cancer Liquid Biopsy Market Forecast
10.3 APAC Breast Cancer Liquid Biopsy Forecast by Region (2025-2030)
10.3.1 China Breast Cancer Liquid Biopsy Market Forecast
10.3.2 Japan Breast Cancer Liquid Biopsy Market Forecast
10.3.3 Korea Breast Cancer Liquid Biopsy Market Forecast
10.3.4 Southeast Asia Breast Cancer Liquid Biopsy Market Forecast
10.3.5 India Breast Cancer Liquid Biopsy Market Forecast
10.3.6 Australia Breast Cancer Liquid Biopsy Market Forecast
10.4 Europe Breast Cancer Liquid Biopsy Forecast by Country (2025-2030)
10.4.1 Germany Breast Cancer Liquid Biopsy Market Forecast
10.4.2 France Breast Cancer Liquid Biopsy Market Forecast
10.4.3 UK Breast Cancer Liquid Biopsy Market Forecast
10.4.4 Italy Breast Cancer Liquid Biopsy Market Forecast
10.4.5 Russia Breast Cancer Liquid Biopsy Market Forecast
10.5 Middle East & Africa Breast Cancer Liquid Biopsy Forecast by Region (2025-2030)
10.5.1 Egypt Breast Cancer Liquid Biopsy Market Forecast
10.5.2 South Africa Breast Cancer Liquid Biopsy Market Forecast
10.5.3 Israel Breast Cancer Liquid Biopsy Market Forecast
10.5.4 Turkey Breast Cancer Liquid Biopsy Market Forecast
10.5.5 GCC Countries Breast Cancer Liquid Biopsy Market Forecast
10.6 Global Breast Cancer Liquid Biopsy Forecast by Type (2025-2030)
10.7 Global Breast Cancer Liquid Biopsy Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Breast Cancer Liquid Biopsy Product Offered
11.1.3 QIAGEN Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Information
11.2.2 Roche Diagnostics Breast Cancer Liquid Biopsy Product Offered
11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Diagnostics Main Business Overview
11.2.5 Roche Diagnostics Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Offered
11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Information
11.4.2 Myriad Genetics Breast Cancer Liquid Biopsy Product Offered
11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Myriad Genetics Main Business Overview
11.4.5 Myriad Genetics Latest Developments
11.5 Menarini Silicon Biosystems
11.5.1 Menarini Silicon Biosystems Company Information
11.5.2 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Offered
11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Menarini Silicon Biosystems Main Business Overview
11.5.5 Menarini Silicon Biosystems Latest Developments
11.6 Genomic Health
11.6.1 Genomic Health Company Information
11.6.2 Genomic Health Breast Cancer Liquid Biopsy Product Offered
11.6.3 Genomic Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Genomic Health Main Business Overview
11.6.5 Genomic Health Latest Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Information
11.7.2 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Offered
11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Thermo Fisher Scientific Main Business Overview
11.7.5 Thermo Fisher Scientific Latest Developments
11.8 Illumina
11.8.1 Illumina Company Information
11.8.2 Illumina Breast Cancer Liquid Biopsy Product Offered
11.8.3 Illumina Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Illumina Main Business Overview
11.8.5 Illumina Latest Developments
11.9 Biocept
11.9.1 Biocept Company Information
11.9.2 Biocept Breast Cancer Liquid Biopsy Product Offered
11.9.3 Biocept Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Biocept Main Business Overview
11.9.5 Biocept Latest Developments
11.10 Trovagene
11.10.1 Trovagene Company Information
11.10.2 Trovagene Breast Cancer Liquid Biopsy Product Offered
11.10.3 Trovagene Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Trovagene Main Business Overview
11.10.5 Trovagene Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Breast Cancer Liquid Biopsy Product Offered
11.11.3 Guardant Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 RainDance Technologies
11.12.1 RainDance Technologies Company Information
11.12.2 RainDance Technologies Breast Cancer Liquid Biopsy Product Offered
11.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RainDance Technologies Main Business Overview
11.12.5 RainDance Technologies Latest Developments
11.13 MDx Health
11.13.1 MDx Health Company Information
11.13.2 MDx Health Breast Cancer Liquid Biopsy Product Offered
11.13.3 MDx Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 MDx Health Main Business Overview
11.13.5 MDx Health Latest Developments
12 Research Findings and Conclusion